Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 58% ± 17% | |
oligodendrocyte precursor cell | 10 studies | 28% ± 12% | |
glutamatergic neuron | 9 studies | 36% ± 23% | |
endothelial cell | 7 studies | 24% ± 6% | |
GABAergic neuron | 7 studies | 48% ± 20% | |
astrocyte | 6 studies | 28% ± 8% | |
neuron | 5 studies | 35% ± 17% | |
interneuron | 5 studies | 44% ± 24% | |
GABAergic interneuron | 3 studies | 29% ± 9% | |
epithelial cell | 3 studies | 22% ± 3% | |
granule cell | 3 studies | 21% ± 3% | |
microglial cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 35% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 12401.84 | 2640 / 2642 | 100% | 102.11 | 705 / 705 |
esophagus | 100% | 3399.46 | 1442 / 1445 | 100% | 48.89 | 183 / 183 |
breast | 100% | 3713.63 | 459 / 459 | 99% | 58.45 | 1112 / 1118 |
prostate | 100% | 3445.31 | 245 / 245 | 99% | 53.67 | 499 / 502 |
thymus | 100% | 3222.51 | 651 / 653 | 99% | 35.52 | 596 / 605 |
ovary | 100% | 3808.52 | 180 / 180 | 97% | 28.45 | 419 / 430 |
lung | 97% | 2653.73 | 562 / 578 | 99% | 40.70 | 1149 / 1155 |
kidney | 100% | 3295.38 | 89 / 89 | 96% | 45.82 | 868 / 901 |
bladder | 100% | 3804.76 | 21 / 21 | 96% | 30.32 | 485 / 504 |
intestine | 100% | 3843.29 | 965 / 966 | 96% | 30.98 | 507 / 527 |
stomach | 98% | 2541.86 | 352 / 359 | 98% | 37.68 | 279 / 286 |
adrenal gland | 100% | 3903.32 | 257 / 258 | 95% | 46.79 | 218 / 230 |
uterus | 100% | 3904.36 | 170 / 170 | 94% | 29.94 | 433 / 459 |
skin | 100% | 5781.87 | 1809 / 1809 | 94% | 47.98 | 444 / 472 |
pancreas | 95% | 2078.86 | 311 / 328 | 99% | 30.48 | 176 / 178 |
liver | 75% | 1052.12 | 169 / 226 | 93% | 25.22 | 378 / 406 |
spleen | 100% | 2798.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.57 | 1 / 1 |
adipose | 100% | 3628.51 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4691.20 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3170.28 | 799 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 24.84 | 28 / 29 |
heart | 91% | 2782.67 | 785 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 21.10 | 68 / 80 |
peripheral blood | 26% | 1050.89 | 242 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0031179 | Biological process | peptide modification |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_1990748 | Biological process | cellular detoxification |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0043295 | Molecular function | glutathione binding |
GO_0050750 | Molecular function | low-density lipoprotein particle receptor binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0004364 | Molecular function | glutathione transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | LANCL1 |
Protein name | Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1) LanC like glutathione S-transferase 1 Glutathione S-transferase LANCL1 (EC 2.5.1.18) (LanC-like protein 1) |
Synonyms | GPR69A hCG_16716 |
Description | FUNCTION: Functions as a glutathione transferase. Catalyzes conjugation of the glutathione (GSH) to artificial substrates 1-chloro-2,4-dinitrobenzene (CDNB) and p-nitrophenyl acetate. Mitigates neuronal oxidative stress during normal postnatal development and in response to oxidative stresses probably through GSH antioxidant defense mechanism (By similarity). May play a role in EPS8 signaling. Binds glutathione . . |
Accessions | ENST00000453956.1 ENST00000412863.1 ENST00000448951.6 H7C2E3 ENST00000233714.8 Q6FHH6 O43813 E9PHS0 ENST00000450366.7 ENST00000441020.7 ENST00000443314.5 F8WDS9 Q53TN2 ENST00000431941.6 |